日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

CheckMate 9ER 随机 III 期试验中，对纳武利尤单抗联合卡博替尼治疗晚期肾细胞癌的最终分析

期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2025.09.006
Motzer, R J; Escudier, B; Burotto, M; Powles, T; Apolo, A B; Bourlon, M T; Shah, A Y; Porta, C; Suárez, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; Scheffold, C; Askelson, M; Panzica, J; Zhang, J; van Kooten Losio, M; Choueiri, T K
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2026
文献求助 收藏

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial

纳武利尤单抗联合卡博替尼对比舒尼替尼一线治疗晚期肾细胞癌：来自 III 期随机 CheckMate 9ER 试验的延长随访结果

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.102994
Powles, T; Burotto, M; Escudier, B; Apolo, A B; Bourlon, M T; Shah, A Y; Suárez, C; Porta, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; George, S; Scheffold, C; Wang, P; Fedorov, V; Motzer, R J; Choueiri, T K
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: using clinical judgement over treatment criteria

恩福妥单抗和帕博利珠单抗在晚期尿路上皮癌患者中的临床应用：以临床判断而非治疗标准为依据

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103725
Apolo, A B; Bellmunt, J; Cordes, L; Gupta, S; Powles, T; Rosenberg, J E; Van Der Heijden, M S
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Effect of stress during slaughter on carcass characteristics and meat quality in tropical beef cattle

屠宰应激对热带肉牛胴体特性和肉质的影响

期刊:Asian-Australasian Journal of Animal Sciences
影响因子:
doi:10.5713/ajas.19.0804
Carrasco-García, Apolo A; Pardío-Sedas, Violeta T; León-Banda, Gloria G; Ahuja-Aguirre, Concepción; Paredes-Ramos, Pedro; Hernández-Cruz, Bertha C; Murillo, Vicente Vega
发表日期：2020
文献求助 收藏

Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer

2016年上尿路尿路上皮癌专题：转移性癌症的治疗

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-016-1885-4
Pham, M N; Apolo, A B; De Santis, M; Galsky, M D; Leibovich, B C; Pisters, L L; Siefker-Radtke, A O; Sonpavde, G; Steinberg, G D; Sternberg, C N; Tagawa, S T; Weizer, A Z; Woods, M E; Milowsky, M I
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions

膀胱癌新辅助化疗的应用：现状调查及观点

期刊:Advances in Urology
影响因子:2.3
doi:10.1155/2014/746298
Cowan, N G; Chen, Y; Downs, T M; Bochner, B H; Apolo, A B; Porter, M P; La Rochelle, J C; Amling, C L; Koppie, T M
肿瘤
肿瘤免疫
膀胱癌
发表日期：2014
文献求助 收藏

Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy

影响 HSP90 靶向治疗的肿瘤内在因素和肿瘤外在因素

期刊:Current Molecular Medicine
影响因子:2.5
doi:10.2174/156652412803306729
Alarcon, S V; Mollapour, M; Lee, M-J; Tsutsumi, S; Lee, S; Kim, Y S; Prince, T; Apolo, A B; Giaccone, G; Xu, W; Neckers, L M; Trepel, J B
肿瘤
HSP90
肿瘤免疫
发表日期：2012
文献求助 收藏